Cbl Proto-Oncogene B, E3 Ubiquitin Protein Ligase (CBLB) anticorps
L’anticorps anti-Cbl Proto-Oncogene B, E3 Ubiquitin Protein Ligase Polyclonal Lapin est utilisé pour la détection de Cbl Proto-Oncogene B, E3 Ubiquitin Protein Ligase dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB et ELISA.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Agent conservateur
ProClin
Précaution d'utilisation
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
Cbl Proto-Oncogene B, E3 Ubiquitin Protein Ligase (CBLB)
Autre désignation
CBLB
Sujet
E3 ubiquitin-protein ligase CBL-B, Casitas B-lineage lymphoma proto-oncogene b, RING finger protein 56, RING-type E3 ubiquitin transferase CBL-B, SH3-binding protein CBL-B, Signal transduction protein CBL-BCBLB (Cbl Proto-Oncogene B) is a Protein Coding gene. Among its related pathways are Chronic myeloid leukemia and Pathways in cancer. GO annotations related to this gene include calcium ion binding and ubiquitin-protein transferase activity. An important paralog of this gene is CBL.